Related Experiment Video
Updated: May 14, 2026

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
Published on: April 16, 2018
The Angiotensin-melatonin axis
Luciana A Campos1, Jose Cipolla-Neto, Fernanda G Amaral
1Center of Innovation, Technology and Education-(CITE), Camilo Castelo Branco University (UNICASTELO), São José dos Campos Technology Park, Presidente Dutra Road Km 138, 12247-004 São José dos Campos, SP, Brazil.
Abstract:
Accumulating evidence indicates that various biological and neuroendocrine circadian rhythms may be disrupted in cardiovascular and metabolic disorders. These circadian alterations may contribute to the progression of disease. Our studies direct to an important role of angiotensin II and melatonin in the modulation of circadian rhythms. The brain renin-angiotensin system (RAS) may modulate melatonin synthesis, a hormone with well-established roles in regulating circadian rhythms. Angiotensin production in the central nervous system may not only influence hypertension but also appears to affect the circadian rhythm of blood pressure. Drugs acting on RAS have been proven effective in the treatment of cardiovascular and metabolic disorders including hypertension and diabetes mellitus (DM). On the other hand, since melatonin is capable of ameliorating metabolic abnormalities in DM and insulin resistance, the beneficial effects of RAS blockade could be improved through combined RAS blocker and melatonin therapy. Contemporary research is evidencing the existence of specific clock genes forming central and peripheral clocks governing circadian rhythms. Further research on the interaction between these two neurohormones and the clock genes governing circadian clocks may progress our understanding on the pathophysiology of disease with possible impact on chronotherapeutic strategies.
Insights
Disrupted circadian rhythms are linked to cardiovascular and metabolic diseases. Angiotensin II and melatonin may regulate these rhythms, offering potential for new chronotherapeutic strategies.
Area of Science:
- Neuroendocrinology
- Cardiovascular Science
- Metabolic Science
Background:
- Circadian rhythm disruptions are implicated in cardiovascular and metabolic disorders.
- The brain renin-angiotensin system (RAS) and melatonin are key neurohormones involved in circadian regulation.
- Existing treatments for hypertension and diabetes mellitus (DM) target the RAS.
Purpose of the Study:
- To investigate the role of angiotensin II and melatonin in modulating circadian rhythms.
- To explore the potential of combined RAS blockade and melatonin therapy for metabolic disorders.
- To examine the interaction between neurohormones and clock genes in circadian regulation.
Main Methods:
- Review of accumulating evidence on circadian rhythms, RAS, and melatonin.
- Analysis of the impact of central nervous system angiotensin production on blood pressure circadian rhythms.
- Consideration of melatonin's effects on metabolic abnormalities in DM and insulin resistance.
Main Results:
- The brain RAS may modulate melatonin synthesis, influencing circadian rhythms.
- Angiotensin II in the central nervous system affects both hypertension and blood pressure circadian rhythms.
- Melatonin can ameliorate metabolic abnormalities in DM and insulin resistance.
Conclusions:
- Combined RAS blockade and melatonin therapy may enhance treatment efficacy for cardiovascular and metabolic disorders.
- Understanding the interaction between neurohormones and clock genes is crucial for advancing chronotherapeutics.
- Further research into these interactions could reveal new pathophysiological insights and treatment strategies.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Hormonal Regulation
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
The Pineal Gland
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...
Management of Insomnia

